Vycor Medical (VYCO) Non-Current Debt (2011 - 2026)
Vycor Medical's (VYCO) quarterly Non-Current Debt came in at $134979.0 in Q1 2026, down 2.58% year-on-year from $138548.0 in Q1 2025, and down 0.63% on a QoQ basis from $135831.0 in Q4 2025.
Vycor Medical (VYCO) Non-Current Debt (2011 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 10 years of Non-Current Debt data on file, last reported at $134979.0 in Q1 2026.
- On a quarterly basis, Non-Current Debt fell 2.58% year-over-year to $134979.0 in Q1 2026; TTM through Mar 2026 was $134979.0, a 2.58% decrease from a year earlier, with the FY2025 full-year figure at $135831.0, down 2.59% from the prior year.
- Non-Current Debt for Q1 2026 stood at $134979.0, down from $135831.0 in the prior quarter.
- Over the last five years, Non-Current Debt for VYCO reached as high as $148681.0 in Q1 2022 and fell as low as $134979.0 in Q1 2026.
- Historically, Non-Current Debt has averaged $141959.9 across 5 years, with a median of $142052.0 in 2024.
- Across the five-year window, Non-Current Debt dropped 0.88% in 2022 and declined 2.59% in 2025, its largest moves.
- Year by year, Non-Current Debt stood at $146253.0 in 2022, then retreated by 2.29% to $142908.0 in 2023, then dropped by 2.43% to $139436.0 in 2024, then retreated by 2.59% to $135831.0 in 2025, then fell by 0.63% to $134979.0 in 2026.
- Per Business Quant data, the three most recent Non-Current Debt figures were $134979.0 in Q1 2026, $135831.0 in Q4 2025, and $136745.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 134,979.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 134,979.00 |
| Dec 31, 2025 | 135,831.00 |
| Sep 30, 2025 | 136,745.00 |
| Jun 30, 2025 | 137,651.00 |
| Mar 31, 2025 | 138,548.00 |
| Dec 31, 2024 | 139,436.00 |
| Sep 30, 2024 | 140,316.00 |
| Jun 30, 2024 | 141,188.00 |
| Mar 31, 2024 | 142,052.00 |
| Dec 31, 2023 | 142,908.00 |
| Sep 30, 2023 | 143,756.00 |
| Jun 30, 2023 | 144,596.00 |
| Mar 31, 2023 | 145,429.00 |
| Dec 31, 2022 | 146,253.00 |
| Sep 30, 2022 | 147,070.00 |
| Jun 30, 2022 | 147,879.00 |
| Mar 31, 2022 | 148,681.00 |
| Dec 31, 2021 | 150,000.00 |
| Sep 30, 2021 | 150,000.00 |
| Jun 30, 2021 | 150,000.00 |